Toevoegen aan een lijst
PDF-rapport : Pacira BioSciences, Inc.
Beurs gesloten -
Andere beurzen
|
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | |
27,81 USD | +1,94% | +3,34% | -27,97% |
Vakgebied
Aantal werknemers : 715
Verkoop per activiteit
USD in miljoenen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Non-opioid Pain Management and Regenerative Health Solutions
100,0
%
| 542 | 100,0 % | 667 | 100,0 % | +23,14% |
Verkoop per regio
USD in miljoenen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 542 | 100,0 % | 667 | 100,0 % | +23,14% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David M. Stack
CEO | Chief Executive Officer | 71 | 2007 |
Director of Finance/CFO | 62 | 2011 | |
Jonathan Slonin
CTO | Chief Tech/Sci/R&D Officer | 48 | 2021 |
Anthony Molloy
CMP | Compliance Officer | 49 | - |
Chief Administrative Officer | 49 | 2011 | |
Chief Tech/Sci/R&D Officer | 57 | 2017 | |
Daryl Gaugler
COO | Chief Operating Officer | 61 | 2019 |
Susan Mesco
IRC | Investor Relations Contact | - | 2015 |
Ron Ellis
PRN | Corporate Officer/Principal | - | - |
Max Reinhardt
PRN | Corporate Officer/Principal | 52 | 2019 |
Bestuurders
Bestuurders | Titel | Leeftijd | Van |
---|---|---|---|
Gary Pace
BRD | Director/Board Member | 75 | 2008 |
David M. Stack
CEO | Chief Executive Officer | 71 | 2007 |
Paul Hastings
BRD | Director/Board Member | 63 | 2011 |
Andreas Wicki
BRD | Director/Board Member | 64 | 2006 |
Laura Brege
BRD | Director/Board Member | 65 | 2011 |
Director/Board Member | 68 | 2013 | |
Mark Froimson
BRD | Director/Board Member | 62 | 2017 |
Director/Board Member | 60 | 2019 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 46 437 704 | 45 879 233 ( 98,80 %) | 0 | 98,80 % |
Bedrijfsgegevens

Sector
Trading rating :
Beleggingsrating :
ESG Refinitiv :
B-
Verkoop
Koop

Gemiddeld advies
Kopen
Aantal analisten
10
Laatste slotkoers
27,81USD
Gemiddelde koersdoel
49,11USD
Spread / Gemiddelde doel
+76,60%
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-27,97% | 1 291 M $ | |
+59,64% | 525 md. $ | |
-10,34% | 381 md. $ | |
-6,75% | 262 md. $ | |
-11,26% | 253 md. $ | |
-17,52% | 221 md. $ | |
+2,14% | 202 md. $ | |
-9,09% | 200 md. $ | |
-43,58% | 163 md. $ | |
+3,74% | 146 md. $ |
- Beurs
- Aandelen
- Aandeel Pacira BioSciences, Inc. - Nasdaq
- Onderneming Pacira BioSciences, Inc.